Alemtuzumab and renal failure acute Patient Reports February 13, 2012

Alemtuzumab Side Effects Report #5868360-2
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Mar 18, 2008. Female patient, 50 years of age, was diagnosed with renal transplant and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: blood culture positive, candidiasis, graft infection, kidney infection, renal failure acute, respiratory failure, urinary tract infection fungal. Alemtuzumab dosage: unknown. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #5863920-7
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5866798-0
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5870151-3
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 18, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.


Alemtuzumab Side Effects Report #5871967-X
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 18, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5977134-3
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 27, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5982292-0
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 27, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute, renal transplant. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #6096839-X
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Feb 14, 2009. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #6101120-6
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Feb 14, 2009. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: goodpasture's syndrome, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.


Alemtuzumab Side Effects Report #5811437-8
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on July 02, 2008. Male patient, 26 years of age, was diagnosed with immunosuppression, alport's syndrome and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory failure, anaemia, dyspnoea, haemoptysis, large intestine perforation, pulmonary alveolar haemorrhage, renal failure acute, renal tubular necrosis, thrombocytopenia. Alemtuzumab dosage: TOTAL DAILY DOSE: 30 MG. During the same period patient was treated with LISINOPRIL, CALCIUM ACETATE, TACROLIMUS. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #5814388-8
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on July 02, 2008. Male patient, 26 years of age, was diagnosed with immunosuppression, alport's syndrome and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory failure, anaemia, dyspnoea, haemoptysis, large intestine perforation, pulmonary alveolar haemorrhage, renal failure acute, renal tubular necrosis, thrombocytopenia. Alemtuzumab dosage: TOTAL DAILY DOSE: 30 MG. During the same period patient was treated with LISINOPRIL, CALCIUM ACETATE, TACROLIMUS. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #6087927-2
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Feb 18, 2009. Male patient, 79 years of age, weighting 218.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: hyperglycaemia, hypomagnesaemia, renal failure acute. Alemtuzumab dosage: 30MG 3 TIMES PER WEEK SQ. During the same period patient was treated with ACYCLOVIR, ALLOPURINOL, ASPIRIN, AVANDIA, BACTRIM DS, FLUCONAZOLE, GLYBURIDE, IMODIUM A. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #5863917-7
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Male patient, 43 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5866799-2
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Male patient, 43 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: dialysis , glomerulonephritis rapidly progressive, nephritis autoimmune, renal failure acute, renal transplant. Alemtuzumab dosage: unknown. Patient recovered.


Alemtuzumab Side Effects Report #5874123-4
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 18, 2008. Male patient, 43 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.